Filing Details
- Accession Number:
- 0001209191-23-049751
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-18 16:22:58
- Reporting Period:
- 2023-09-15
- Accepted Time:
- 2023-09-18 16:22:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1699382 | Pmv Pharmaceuticals Inc. | PMVP | Pharmaceutical Preparations (2834) | 463218129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1825216 | Leila Alland | C/O Pmv Pharmaceuticals, Inc. One Research Way Princeton NJ 08540 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-09-15 | 6,291 | $6.62 | 45,909 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
Billionaire Hedge Funds
